Note 12 - Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Research and development expense | $ 13,390 | $ 13,054 |
| General and administrative expense | 6,909 | 4,912 |
| Other income | 1,982 | 1,333 |
| Net loss | (18,317) | (16,633) |
| Personnel [Member] | ||
| Research and development expense | 4,592 | 3,199 |
| General and administrative expense | 4,914 | 3,301 |
| General [Member] | ||
| Research and development expense | 1,336 | 1,213 |
| General and administrative expense | 1,995 | 1,611 |
| Tovecimig [Member] | ||
| Research and development expense | 4,976 | 6,677 |
| CTX-471 [Member] | ||
| Research and development expense | 858 | 699 |
| CTX-8371 [Member] | ||
| Research and development expense | 783 | 529 |
| CTX-10726 [Member] | ||
| Research and development expense | $ 845 | $ 737 |
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|